Publications by the researcher in collaboration with José Ramón González Juanatey (11)
2023
-
Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study
American Journal of Cardiovascular Drugs, Vol. 23, Núm. 5, pp. 583-593
2022
-
Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors
Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 5, pp. 245-252
2021
-
A New Biomarker Tool for Risk Stratification in “de novo” Acute Heart Failure (OROME)
Frontiers in Physiology, Vol. 12
2020
-
CD5L, Macrophage Apoptosis Inhibitor, Was Identified in Epicardial Fat-Secretome and Regulated by Isoproterenol From Patients With Heart Failure
Frontiers in Physiology, Vol. 11
-
Inflammatory and lipid regulation by cholinergic activity in epicardial stromal cells from patients who underwent open-heart surgery
Journal of Cellular and Molecular Medicine, Vol. 24, Núm. 18, pp. 10958-10969
2019
-
A prospective study of the clinical outcomes and prognosis associated with comorbid COPD in the atrial fibrillation population
International Journal of COPD, Vol. 14, pp. 371-380
-
Inflammatory effects of in vivo glycated albumin from cardiovascular patients
Biomedicine and Pharmacotherapy, Vol. 113
-
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
The Lancet, Vol. 394, Núm. 10204, pp. 1169-1180
2017
-
Cardiovascular efficacy and safety of bococizumab in high-risk patients
New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539
-
Clinical profile and outcomes in octogenarians with atrial fibrillation: A community-based study in a specific European health care area
International Journal of Cardiology, Vol. 243, pp. 211-215
2013
-
Left bundle branch block in atrial fibrillation patients without heart failure
International Journal of Cardiology, Vol. 168, Núm. 6, pp. 5460-5462